241 related articles for article (PubMed ID: 21530172)
1. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings.
Mendis S; Lindholm LH; Anderson SG; Alwan A; Koju R; Onwubere BJ; Kayani AM; Abeysinghe N; Duneas A; Tabagari S; Fan W; Sarraf-Zadegan N; Nordet P; Whitworth J; Heagerty A
J Clin Epidemiol; 2011 Dec; 64(12):1451-62. PubMed ID: 21530172
[TBL] [Abstract][Full Text] [Related]
2. Challenges for the management of hypertension in low-resource settings.
Mendis S
Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
[TBL] [Abstract][Full Text] [Related]
3. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries.
Mendis S; Lindholm LH; Mancia G; Whitworth J; Alderman M; Lim S; Heagerty T
J Hypertens; 2007 Aug; 25(8):1578-82. PubMed ID: 17620952
[TBL] [Abstract][Full Text] [Related]
4. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
Ene-Iordache B; Perico N; Bikbov B; Carminati S; Remuzzi A; Perna A; Islam N; Bravo RF; Aleckovic-Halilovic M; Zou H; Zhang L; Gouda Z; Tchokhonelidze I; Abraham G; Mahdavi-Mazdeh M; Gallieni M; Codreanu I; Togtokh A; Sharma SK; Koirala P; Uprety S; Ulasi I; Remuzzi G
Lancet Glob Health; 2016 May; 4(5):e307-19. PubMed ID: 27102194
[TBL] [Abstract][Full Text] [Related]
6. Recent trends and sociodemographic distribution of cardiovascular risk factors: results from two population surveys in the Austrian WHO CINDI demonstration area.
Ulmer H; Diem G; Bischof HP; Ruttmann E; Concin H
Wien Klin Wochenschr; 2001 Aug; 113(15-16):573-9. PubMed ID: 11571834
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
[TBL] [Abstract][Full Text] [Related]
8. Trends in cardiovascular disease risk factor clustering in eastern Finland: results of 15-year follow-up of the North Karelia Project.
Jousilahti P; Tuomilehto J; Korhonen HJ; Vartiainen E; Puska P; Nissinen A
Prev Med; 1994 Jan; 23(1):6-14. PubMed ID: 8016034
[TBL] [Abstract][Full Text] [Related]
9. [Factors of cardiovascular risk for hypertensive patients followed during primary care].
Ben Abdelaziz A; Elrafei W; Gaha K; Mandhouj O; Ben Othman A; Ghannem H
Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724
[TBL] [Abstract][Full Text] [Related]
10. Clustering of cardiovascular risk factors in a middle-income country: a call for urgency.
Selvarajah S; Haniff J; Kaur G; Hiong TG; Cheong KC; Lim CM; Bots ML;
Eur J Prev Cardiol; 2013 Apr; 20(2):368-75. PubMed ID: 22345688
[TBL] [Abstract][Full Text] [Related]
11. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa.
Longo-Mbenza B; Ngoma DV; Nahimana D; Mayuku DM; Fuele SM; Ekwanzala F; Beya C
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):503-8. PubMed ID: 18830083
[TBL] [Abstract][Full Text] [Related]
12. WHO/ISH total risk approach for primary prevention of cardiovascular disease shows greater decrease in costs for women but not the elderly in Jamaica.
Abdulkadri AO; Tulloch-Reid MK; Francis DK; Gordon-Strachan GM; Younger-Coleman NO; Rocke KD; McFarlane SR; Cunningham-Myrie CA; Ferguson TS; Wilks RJ; Anderson SG
J Clin Epidemiol; 2015 Sep; 68(9):994-1001. PubMed ID: 25819490
[TBL] [Abstract][Full Text] [Related]
13. Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis.
Mirmiran P; Esmaillzadeh A; Azizi F
Eur J Clin Nutr; 2004 Aug; 58(8):1110-8. PubMed ID: 15280905
[TBL] [Abstract][Full Text] [Related]
14. Gap between evidence and physicians' knowledge and practice regarding hypertension and its drug treatment: a survey in a Chinese city.
Wang WZ; Tang JL; Hu YH; An JG; Wang YL; Ren ZH; Zhang H; Griffiths S
Chin Med J (Engl); 2011 Apr; 124(8):1235-41. PubMed ID: 21543003
[TBL] [Abstract][Full Text] [Related]
15. Can we prevent cardiovascular diseases in low- and middle-income countries?
Lenfant C
Bull World Health Organ; 2001; 79(10):980-2; discussion 983-7. PubMed ID: 11693981
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.
Gaziano TA; Steyn K; Cohen DJ; Weinstein MC; Opie LH
Circulation; 2005 Dec; 112(23):3569-76. PubMed ID: 16330698
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.
Gersh BJ; Sliwa K; Mayosi BM; Yusuf S
Eur Heart J; 2010 Mar; 31(6):642-8. PubMed ID: 20176800
[TBL] [Abstract][Full Text] [Related]
18. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study.
Zamorano J; Erdine S; Lopez AP; Kim JH; Al Khadra A; Westergaard M; Sutradhar S; Yunis C;
Postgrad Med; 2010 Mar; 122(2):7-15. PubMed ID: 20203451
[TBL] [Abstract][Full Text] [Related]
19. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
20. [Cost-effectiveness analysis of cardiovascular disease prevention: a graded list as aid to the rational distribution of resources].
Lindholm L; Hallgren CG; Boman K; Markgren K; Weinehall L; Ogren JE
Lakartidningen; 1999 Jun; 96(23):2858-63, 2865-6. PubMed ID: 10405534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
